Cancer immunotherapy using interleukin-2 and interleukin-2-activated lymphocytes

Annu Rev Immunol. 1986;4:681-709. doi: 10.1146/annurev.iy.04.040186.003341.
No abstract available

Publication types

  • Clinical Trial
  • Review

MeSH terms

  • Animals
  • Clinical Trials as Topic
  • Drug Tolerance
  • Humans
  • Immunization, Passive
  • Immunotherapy / methods*
  • Interleukin-2 / administration & dosage
  • Interleukin-2 / immunology*
  • Killer Cells, Natural / immunology
  • Lymphocyte Activation
  • Lymphocytes / immunology*
  • Lymphokines / immunology
  • Mice
  • Neoplasms / immunology
  • Neoplasms / therapy*
  • Neoplasms, Experimental / immunology
  • Neoplasms, Experimental / therapy
  • Rats

Substances

  • Interleukin-2
  • Lymphokines